Tuxarin ER FDA Approval History
FDA Approved: Yes (First approved June 22, 2015)
Brand name: Tuxarin ER
Generic name: chlorpheniramine and codeine
Dosage form: Extended Release Tablets
Company: Mainpointe Pharmaceuticals
Treatment for: Cough, Cold Symptoms
Tuxarin ER (codeine and chlorpheniramine) is a long acting narcotic antitussive and antihistamine combination for the treatment of cough and cold symptoms.
Development timeline for Tuxarin ER
| Date | Article |
|---|---|
| Jul 1, 2015 | Approval Spriaso Announces FDA Approval of Long Acting Tuxarin ER (codeine and chlorpheniramine) |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.